Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes-Reference-Cited by-同舟云学术

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes

Published:2003-03-24 Issue:4 Volume:21 Page:405-413
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Koehne Guenther,Doubrovin Mikhail,Doubrovina Ekaterina,Zanzonico Pat,Gallardo Humilidad F.,Ivanova Anna,Balatoni Julius,Teruya-Feldstein Julie,Heller Glenn,May Chad,Ponomarev Vladimir,Ruan Shutian,Finn Ronald,Blasberg Ronald G.,Bornmann William,Riviere Isabelle,Sadelain Michel,O'Reilly Richard J.,Larson Steven M.,Gelovani Tjuvajev Juri G.

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt805.pdf

Reference43 articles.

1. Papadopoulos, E.B. et al. Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation. N. Engl. J. Med. 330, 1185–1191 (1994).

2. Heslop, H.E., Brenner, M.K. & Rooney, C.M. Donor T-cells to treat EBV-associated lymphoma. N. Engl. J. Med. 331, 679–680 (1994).

3. Riddell, S.R. et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T-cell clones. Science 257, 238–241 (1992).

4. Rooney, C.M. et al. Use of gene-modified virus-specific T-lymphocytes to control Epstein-Barr-virus–related lymphoproliferation. Lancet 345, 9–13 (1995).

5. Kolb, H.J. et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76, 2462–2465 (1990).

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo;Science Advances;2024-08-23

2. CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison;Experimental Hematology & Oncology;2024-05-14

3. Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation;Frontiers in Immunology;2024-01-11

4. Cellular Therapy with Engineered T Cells, Efficacy, and Side Effects: Gene Editing/Gene Therapy;The EBMT Handbook;2024

5. Experimental techniques for detecting and evaluating the amyloid fibrils;Progress in Molecular Biology and Translational Science;2024